Plasmodium Falciparum Malaria
📧 Sign up to get email alerts when something new happens for Plasmodium Falciparum Malaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants [Phase 1]
A Phase 1 study to assess the safety of GSK4024484 in healthy adults is actively recruiting, sponsored by GlaxoSmithKline, for Plasmodium fa…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: R21/MM Dosing, Presentations, and Preservatives [Phase 4]
This clinical trial update covers Phase 4 dosing for the R21/MM malaria vaccine, along with recent presentations and preservatives used in t…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety, immunogenicity, and ex-vivo efficacy of two candidate malaria transmission-blocking vaccines…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Mass Vaccine and Drug Administration, Bangladesh [Phase 4]
This is an update on a Phase 4 clinical trial in Bangladesh evaluating mass vaccine and drug administration for Plasmodium falciparum malari…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia [Phase 3]
PATH-sponsored Phase 3 clinical trial in Ethiopia evaluating targeted antimalarial drug administration for seasonal migrant populations in t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy [Phase 4]
A Phase 4 clinical trial in Uganda is assessing transmission of artemisinin-resistant parasites before and after conventional artemisinin-ba…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers [Phase 1]
Phase 1 clinical trial evaluating safety, tolerability, and pharmacokinetics of different orally administered regimens of the ZY19489-Ferroq…
-
CLINICAL_TRIALS research · 2020-01-30Clinical Trial Update: Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum Transmission [Phase 2, Phase 3]
A clinical trial evaluating Pyronaridine-artesunate with low-dose primaquine to prevent transmission of Plasmodium falciparum malaria (Phase…
-
CLINICAL_TRIALS research · 2015-06-15Clinical Trial Update: Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria [Phase 2]
A Phase 2 trial evaluating fosmidomycin in combination with piperaquine for acute uncomplicated Plasmodium falciparum malaria is being condu…
-
CLINICAL_TRIALS research · 2011-05-26Clinical Trial Update: Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria [Phase 2]
This clinical trial update describes a Phase 2 study evaluating fosmidomycin in combination with clindamycin for acute uncomplicated Plasmod…
-
CLINICAL_TRIALS research · 2010-02-25Clinical Trial Update: Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan [Phase 4]
This clinical trial update compares dihydroartemisinin-piperaquine with artemether-lumefantrine for treating uncomplicated Plasmodium falcip…